| Autor: |
Stergiou GS; Hypertension Center, Third University Department of Medicine, Sotira Hospital, Athens, Greece. gstergi@med.uoa.gr, Efstathiou SP, Skeva II, Baibas NM, Kalkana CB, Mountokalakis TD |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of human hypertension [J Hum Hypertens] 2002 Oct; Vol. 16 (10), pp. 729-35. |
| DOI: |
10.1038/sj.jhh.1001477 |
| Abstrakt: |
This study investigated the differences in the effect of an angiotensin converting enzyme inhibitor (ACEI) compared with an angiotensin receptor blocker (ARB) on blood pressure (BP) and pulse pressure (PP) measured in the clinic (CBP and CPP, respectively), at home (HBP, HPP) and with ambulatory monitoring (ABP, APP). Twenty-seven hypertensive patients were randomised to receive lisinopril (20 mg) or losartan (50 mg) for 5 weeks, and were subsequently crossed-over to the alternative treatment for a second 5-week period. Measurements of CBP, 24-h ABP and 5-days HBP were performed before randomisation and at the end of each treatment period. All measurement methods showed that lisinopril was more effective than losartan in reducing BP. However, the difference between the two drugs was demonstrated with greater precision using HBP (P<0.001) than 24-h ABP (P<0.01), whereas the poorest precision for demonstrating this difference was provided by CBP (P<0.05). Lisinopril was also found more effective than losartan in reducing HPP (P=0.01) and 24-h APP (P=0.03) whereas no such a difference was detected using measurements of CPP. It was concluded that the antihypertensive drugs may differ in their effects not only on BP, but also on PP. HBP monitoring appears to be as reliable as 24-h ABP monitoring in detecting differences in the effect of drugs on both BP and PP. Clinic measurements seem to be the least reliable method, particularly in the detection of differences in PP. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
